Lincoln Pharmaceuticals consolidated net profit declines 56.89% in the June 2017 quarter
Sales rise 51.26% to Rs 134.86 crore
Net profit of Lincoln Pharmaceuticals declined 56.89% to Rs 4.91 crore in the quarter ended June 2017 as against Rs 11.39 crore during the previous quarter ended June 2016. Sales rose 51.26% to Rs 134.86 crore in the quarter ended June 2017 as against Rs 89.16 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales134.8689.16 51 OPM %5.2116.94 -PBDT8.2516.52 -50 PBT6.8715.14 -55 NP4.9111.39 -57Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 14 2017 | 1:57 PM IST